All Stories

  1. Encompassing the complexity of personality to understand its association with disability in multiple sclerosis
  2. Altered Hippocampal Structure-Function Coupling and Brain-Cognition Aging Profile in Mild Cognitive Impairment
  3. Cognitive Trajectories of Older Adults Before and After the COVID-19 Pandemic: Socio-economic and Psychological Disparities in the Lc65+ Cohort
  4. Brain connectivity as a new target for Alzheimer’s disease therapy?
  5. Brain Connectivity Gradients Alterations in Discordant Cerebrospinal Fluid Profile for Alzheimer's Disease Biomarkers
  6. Medical risk factors, ApoE haplotype, and Alzheimer’s disease: a large-scale analysis
  7. Tense production in French-speaking participants with Alzheimer's disease: What about discourse? Contribution of a storytelling-in-sequence task
  8. Linking Personality Traits to Disability Progression in Multiple Sclerosis: A Longitudinal Analysis
  9. Brain health services for the secondary prevention of cognitive impairment and dementia: Opportunities, challenges, and the business case for existing and future facilities
  10. Anti-Amyloid Monoclonal Antibodies for the Treatment of Alzheimer Disease: Intersocietal Recommendations for Their Appropriate Use in Switzerland
  11. Biomarkers do not paint the whole picture: The role of clinical expertise and advanced neuroimaging for Alzheimer's disease diagnosis
  12. Association of Motoric Cognitive Risk Syndrome and High C-Reactive Protein Serum Levels With Incident Major Neurocognitive Disorder: Results From the Quebec NuAge Cohort
  13. Can brain network connectivity facilitate the clinical development of disease-modifying anti-Alzheimer drugs?
  14. Anti-Amyloid Drugs for Alzheimer’s Disease: Considering the Role of Depression
  15. Functional dynamic network connectivity differentiates biological patterns in the Alzheimer's disease continuum
  16. Reader Response: Eligibility for Anti-Amyloid Treatment in a Population-Based Study of Cognitive Aging
  17. Normal pressure hydrocephalus and cognitive impairment: The gait phenotype matters too
  18. Markers of limbic system damage following SARS-CoV-2 infection
  19. Impact of Subjective Evaluations in Predicting Response to Ventriculoperitoneal Shunt for Idiopathic Normal Pressure Hydrocephalus
  20. Long COVID Neuropsychological Deficits after Severe, Moderate, or Mild Infection
  21. Functional connectivity underlying cognitive and psychiatric symptoms in post-COVID-19 syndrome: is anosognosia a key determinant?
  22. Gait stability in ambulant children with cerebral palsy during dual tasks
  23. The Two-Way Route between Delirium Disorder and Dementia: Insights from COVID-19
  24. “Emergency Room Evaluation and Recommendations” and Incident Hospital Admissions in Older People with Major Neurocognitive Disorders Visiting Emergency Department: Results of an Experimental Study
  25. Decrease in pain perception during acute SARS-CoV-2 infection: a case series
  26. COVID-19 associated stroke and cerebral endotheliitis
  27. COVID‐19 encephalopathy: Clinical and neurobiological features
  28. Beyond silent hypoxemia: Does COVID‐19 can blunt pain perception? Comment on “The neuroinvasive potential of SARS CoV2 may play a role in the respiratory failure of COVID 19 patients”
  29. Normal pressure hydrocephalus and CSF tap test response: the gait phenotype matters
  30. Dyspnea: The vanished warning symptom of COVID‐19 pneumonia
  31. Smoothness of Gait in Healthy and Cognitively Impaired Individuals: A Study on Italian Elderly Using Wearable Inertial Sensor
  32. Commentary: Prevalence of Alternative Diagnoses and Implications for Management in Idiopathic Normal Pressure Hydrocephalus Patients
  33. Motoric cognitive risk syndrome and incident dementia: results from a population‐based prospective and observational cohort study
  34. Structural Brain Volume Covariance Associated with Gait Speed in Patients with Amnestic and Non-Amnestic Mild Cognitive Impairment: A Double Dissociation
  35. Deconstructing or reestablishing frontal gait in normal pressure hydrocephalus?
  36. Is frontal gait a myth in normal pressure hydrocephalus?
  37. Motoric cognitive risk syndrome and mortality: results from the EPIDOS cohort
  38. The relationship between depression, anxiety and cognition and its paradoxical impact on falls in multiple sclerosis patients
  39. Dopaminergic imaging separates normal pressure hydrocephalus from its mimics
  40. Brain comorbidities in normal pressure hydrocephalus
  41. Neural correlates of gait variability in people with multiple sclerosis with fall history
  42. Parkinsonism is a Phenotypical Signature of Amyloidopathy in Patients with Gait Disorders
  43. Spatiotemporal Gait Characteristics Associated with Cognitive Impairment: A Multicenter Cross-Sectional Study, the Intercontinental "Gait, cOgnitiOn & Decline" Initiative
  44. Brain comorbidities in normal pressure hydrocephalus
  45. Apathy in idiopathic normal pressure hydrocephalus: A marker of reversible gait disorders
  46. Gait stability in patients treated by fingolimod: A longitudinal pilot study on 9 patients with multiple sclerosis
  47. Does fear of falling predict gait variability in multiple sclerosis?
  48. CSF tapping also improves mental imagery of gait in normal pressure hydrocephalus
  49. Gait variability at fast-pace walking speed: A biomarker of mild cognitive impairment?
  50. Erratum
  51. The influence of individual motor imagery ability on cerebral recruitment during gait imagery
  52. Contribution of Brain Imaging to the Understanding Of Gait Disorders in Alzheimer’s Disease
  53. Derivation and validation of a Short Form of the Mini-Mental State Examination for the screening of dementia in older adults with a memory complaint
  54. Gait and motor imagery of gait in early schizophrenia
  55. Effects of amygdala–hippocampal stimulation on interictal epileptic discharges
  56. Vitamin D insufficiency and mild cognitive impairment: cross-sectional association
  57. Adapted Timed Up and Go: A Rapid Clinical Test to Assess Gait and Cognition in Multiple Sclerosis
  58. Gait control: a specific subdomain of executive function?
  59. Does Memantine Improve the Gait of Individuals with Alzheimer's Disease?
  60. Development of a short form of Mini-Mental State Examination for the screening of dementia in older adults with a memory complaint: a case control study
  61. Association Between High Variability of Gait Speed and Mild Cognitive Impairment: A Cross-Sectional Pilot Study
  62. Timed up and go test and risk of falls in older adults: A systematic review
  63. Biology of gait control: Vitamin D involvement
  64. Test-retest reliability of stride time variability while dual tasking in healthy and demented adults with frontotemporal degeneration
  65. Poor creativity in frontotemporal dementia: A window into the neural bases of the creative mind
  66. Interest of dual-task-related gait changes in idiopathic normal pressure hydrocephalus
  67. Decrease in gait variability while counting backward: a marker of “magnet effect”?
  68. Imagined Timed Up & Go test: A new tool to assess higher-level gait and balance disorders in older adults?
  69. EFFECT OF PSYCHOACTIVE MEDICATION ON GAIT VARIABILITY IN COMMUNITY-DWELLING OLDER ADULTS: A CROSS-SECTIONAL STUDY
  70. Antiepileptic drugs modify power of high EEG frequencies and their neural generators
  71. Frontotemporal dementia: Pathology of gait?
  72. Vitamin D and cognitive performance in adults: a systematic review
  73. Association of vitamin D deficiency with cognitive impairment in older women: Cross-sectional study
  74. Stops walking when talking: a predictor of falls in older adults?
  75. Gait Variability among Healthy Adults: Low and High Stride-to-Stride Variability Are Both a Reflection of Gait Stability
  76. Walking speed-related changes in stride time variability: effects of decreased speed
  77. Frontal Assessment Battery is a marker of dorsolateral and medial frontal functions: A SPECT study in frontotemporal dementia
  78. Recurrent Falls and Dual Task–Related Decrease in Walking Speed: Is There a Relationship?
  79. GALANTAMINE IMPROVES GAIT PERFORMANCE IN PATIENTS WITH ALZHEIMER'S DISEASE
  80. Concurrent validity of SMTEC® footswitches system for the measurement of temporal gait parameters
  81. Does Change in Gait while Counting Backward Predict the Occurrence of a First Fall in Older Adults?
  82. Dual Task–Related Changes in Gait Performance in Older Adults: A New Way of Predicting Recurrent Falls?
  83. Impact of Impaired Executive Function on Gait Stability
  84. Changes in gait while backward counting in demented older adults with frontal lobe dysfunction
  85. Mild clinical expression of Lambert Eaton myasthenic syndrome in a patient with HIV infection
  86. 'Faster counting while walking' as a predictor of falls in older adults
  87. Is low lower-limb kinematic variability always an index of stability?
  88. Myasthenia gravis associated with HTLV-I infection and atypical brain lesions
  89. LONG-TERM PRACTICE OF JAQUES-DALCROZE EURHYTHMICS PREVENTS AGE-RELATED INCREASE OF GAIT VARIABILITY UNDER A DUAL TASK